S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades|
|Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference|
|Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014|
|3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics’ Donor Management System|
|Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance|
|Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)|
|BioCryst Reports Third Quarter 2014 Financial Results|
|Dyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930|
|BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress|
|Dyax Corp. to Participate in the Leerink Partners Rare Disease Roundtable|
Click above to view more mutual fund data and stats for hae - Haemonetics Corp.